Skip to main content
NCBI home page
Revista da Sociedade Brasileira de Medicina Tropical logoLink to Revista da Sociedade Brasileira de Medicina Tropical
. 2023 Dec 8;56:e0549-2023. doi: 10.1590/0037-8682-0549-2023

Guidelines for Trypanosoma cruzi-HIV Co-infection and other Immunosuppressive Conditions: Diagnosis, Treatment, Monitoring, and Implementation from the International Network of Care and Studies - 2023

Eros Antonio de Almeida 1, Fernanda de Souza Nogueira Sardinha Mendes 2, Alberto Novaes Ramos Júnior 3, Andréa Silvestre de Sousa 2, Tycha Bianca Sabaini Pavan 4, Mauro Felippe Felix Mediano 2, Alejandro Luquetti Ostermayer 5, Alejandro Marcel Hasslocher-Moreno 2, Constança Felicia De Paoli de Carvalho Britto 6, Christina Gallafrio Novaes 7, Dalmo Correia 8, Fred Luciano Neves Santos 4, Gilberto Marcelo Sperandio da Silva 2, Marisa Liliana Fernandez 9, Mayara Maia Lima 10, Noêmia Barbosa de Carvalho 7, Otacílio da Cruz Moreira 11, Pedro Albajar-Viñas 12, Ruth Moreira Leite 13, Swamy Lima Palmeira 10, Veruska Maia da Costa 10, Maria Aparecida Shikanai Yasuda 7
PMCID: PMC10706049  PMID: 38088667

The content is available as a PDF (3.3 MB).

REFERENCES

  • 1.Dias JC, Ramos AN, Jr, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. 2nd Brazilian Consensus on Chagas Disease, 2015. Rev Soc Bras Med Trop. 2016;49(Suppl 1):3–60. doi: 10.1590/0037-8682-0505-2016. [DOI] [PubMed] [Google Scholar]
  • 2.Ramos AN., Jr Recomendações para diagnóstico, tratamento e acompanhamento da co-infecção Trypanosoma cruzi: vírus da imunodeficiência humana. Rev Soc Bras Med Trop. 2006;39(4):392–415. doi: 10.1590/S0037-86822006000400017. [DOI] [PubMed] [Google Scholar]
  • 3.Shikanai-Yasuda MA, Mediano MFF, Novaes CTG, Sousa AS, Sartori AMC, Santana RC, et al. Correction: Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions". PLoS Negl Trop Dis. 2023;17(1):e0011036. doi: 10.1371/journal.pntd.0011036. Erratum for: PLoS Negl Trop Dis . 2021 Sep 30;15(9):e0009809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ministério da Saúde (MS). Comissão Nacional de Incorporação de Tecnologias no SUS (CONITEC) Protocolo Clínico e Diretrizes Terapêuticas Doença de Chagas. Brasília: MS; 2018. 135 p. http://antigo-conitec.saude.gov.br/images/PCDT_Doenca_de_Chagas.pdf [Google Scholar]
  • 5.Stanaway JD, Roth G. The burden of Chagas disease: estimates and challenges. Glob Heart. 2015;10(3):139–144. doi: 10.1016/j.gheart.2015.06.001. [DOI] [PubMed] [Google Scholar]
  • 6.Shikanai Yasuda MA. Emerging and reemerging forms of Trypanosoma cruzi transmission. Mem Inst Oswaldo Cruz. 2022;117:e210033. doi: 10.1590/0074-02760210033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chagas C. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz. 1909;1(2):159–218. doi: 10.1590/s0074-02761909000200008. [DOI] [Google Scholar]
  • 8.World Health Organization (WHO) Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015;90(6):33–43. [PubMed] [Google Scholar]
  • 9.Apt W, Zulantay I. Estado actual en el tratamiento de la enfermedad de Chagas [Update on the treatment of Chagas' disease] Rev Med Chil. 2011;139(2):247–257. doi: 10.4067/S0034-98872011000200016. [DOI] [PubMed] [Google Scholar]
  • 10.Sartori AM, Ibrahim KY, Nunes Westphalen EV, Braz LM, Oliveira OC, Jr, Gakiya E, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol. 2007;101(1):31–50. doi: 10.1179/136485907X154629. [DOI] [PubMed] [Google Scholar]
  • 11.Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007;115(9):1124–1131. doi: 10.1161/CIRCULATIONAHA.106.627323. [DOI] [PubMed] [Google Scholar]
  • 12.Dias JC. The indeterminate form of human chronic Chagas' disease A clinical epidemiological review. Rev Soc Bras Med Trop. 1989;22(3):147–156. doi: 10.1590/S0037-86821989000300007. [DOI] [PubMed] [Google Scholar]
  • 13.Almeida EA. Epidemiologia e clínica da coinfecção Trypanosoma cruzi e vírus da imunodeficiência adquirida. 1st ed. Campinas: Unicamp; 2015. 328 p [Google Scholar]
  • 14.Lattes R, Linares L, Radisic M. Emerging parasitic infections in transplantation. Curr Infect Dis Rep. 2012;14(6):642–649. doi: 10.1007/s11908-012-0295-z. [DOI] [PubMed] [Google Scholar]
  • 15.Cavalcanti MAF, Neta FI, Benevides DHJ, Andrade CM, Nascimento EGC. Caracterizando o perfil de mortalidade da doença de Chagas no Brasil; ANAIS MEDTROP; 2016. [Google Scholar]
  • 16.Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391(10115):82–94. doi: 10.1016/S0140-6736(17)31612-4. [DOI] [PubMed] [Google Scholar]
  • 17.Pinto Dias JC. Human chagas disease and migration in the context of globalization: some particular aspects. J Trop Med. 2013;2013:789758–789758. doi: 10.1155/2013/789758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ferreira I de LM, Silva TPT e. Eliminação da transmissão da doença de Chagas pelo Triatoma infestans no Brasil: um fato histórico. Rev Soc Bras Med Trop. 2006;39(5):507–509. doi: 10.1590/S0037-86822006000500018. [DOI] [PubMed] [Google Scholar]
  • 19.World Health Organization (WHO) Chagas disease (American trypanosomiasis) - fact sheet (revised in August 2012) Wkly Epidemiol Rec. 2012;87(51/52):519–522. [Google Scholar]
  • 20.Organización Panamericana de la Salud Guía para el diagnóstico y el tratamiento de la enfermedad de Chagas. 2019. http://iris.paho.org/xmlui/handle/10665.2/49653
  • 21.Freilij H, Altcheh J, Muchinik G. Perinatal human immunodeficiency virus infection and congenital Chagas' disease. Pediatr Infect Dis J. 1995;14(2):161–162. [PubMed] [Google Scholar]
  • 22.Rassi A, Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (Chagas disease) Infect Dis Clin North Am. 2012;26(2):275–291. doi: 10.1016/j.idc.2012.03.002. [DOI] [PubMed] [Google Scholar]
  • 23.Martins-Melo FR, Ramos AN, Jr, Alencar CH, Heukelbach J. Mortality Related to Chagas Disease and HIV/AIDS Coinfection in Brazil. J Trop Med. 2012;2012:534649–534649. doi: 10.1155/2012/534649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.D'Albuquerque LA, Gonzalez AM, VN HL, Filho, Copstein JL, Larrea FI, Mansero JM, et al. Liver transplantation from deceased donors serologically positive for Chagas disease. Am J Transplant. 2007;7(3):680–684. doi: 10.1111/j.1600-6143.2007.01663.x. [DOI] [PubMed] [Google Scholar]
  • 25.Organización Panamericana de la Salud Enfermedad de Chagas e inmunosupresión. Decálogo para la prevención, el diagnóstico y el tratamiento. 2021. https://iris.paho.org/handle/10665.2/54561
  • 26.Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd ed. Geneva: World Health Organization; 2016. https://www.who.int/publications/i/item/9789241549684 [PubMed] [Google Scholar]
  • 27.Almeida EA, Ramos AN, Júnior, Correia D, Shikanai-Yasuda MA. Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010) Rev Soc Bras Med Trop. 2011;44(6):762–770. doi: 10.1590/S0037-86822011000600021. [DOI] [PubMed] [Google Scholar]
  • 28.Jannin J. Presentation of the consensus workshop about the Chagas disease in non-endemic areas (26 June 2009, Paris, France) Bull Soc Pathol Exot. 2009;102(5):275–275. [PubMed] [Google Scholar]
  • 29.Almeida EA, Lima JN, Lages-Silva E, Guariento ME, Aoki FH, Torres-Morales AE, et al. Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg. 2010;104(7):447–452. doi: 10.1016/j.trstmh.2010.02.004. [DOI] [PubMed] [Google Scholar]
  • 30.Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis. 2008;12(6):587–592. doi: 10.1016/j.ijid.2007.12.007. [DOI] [PubMed] [Google Scholar]
  • 31.Lopez-Albizu C, Bravo MP, Pico M, Fernandez ML. Case report of Chagas disease reactivation: new diagnosis tool by direct microscopic observation of biopsy specimen and its preservation fluid. Rev Soc Bras Med Trop. 2020;54:e20200326. doi: 10.1590/0037-8682-0326-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sartori AM, E J, Neto, Nunes EV, Braz LM, Caiaffa-Filho HH, Oliveira Oda C, Jr, et al. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis. 2002;186(6):872–875. doi: 10.1086/342510. [DOI] [PubMed] [Google Scholar]
  • 33.Benvenuti LA, Roggério A, Sambiase NV, Fiorelli A, Higuchi Mde L. Polymerase chain reaction in endomyocardial biopsies for monitoring reactivation of Chagas' disease in heart transplantation: a case report and review of the literature. Cardiovasc Pathol. 2005;14(5):265–268. doi: 10.1016/j.carpath.2005.06.001. [DOI] [PubMed] [Google Scholar]
  • 34.Benvenuti LA, Roggério A, Coelho G, Fiorelli AI. Usefulness of qualitative polymerase chain reaction for Trypanosoma cruzi DNA in endomyocardial biopsy specimens of chagasic heart transplant patients. J Heart Lung Transplant. 2011;30(7):799–804. doi: 10.1016/j.healun.2011.02.012. [DOI] [PubMed] [Google Scholar]
  • 35.Burgos JM, Diez M, Vigliano C, Bisio M, Risso M, Duffy T, et al. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clin Infect Dis. 2010;51(5):485–495. doi: 10.1086/655680. [DOI] [PubMed] [Google Scholar]
  • 36.Cuna WR, Choque AG, Passera R, Rodriguez C. Pro-inflammatory cytokine production in chagasic mothers and their uninfected newborns. J Parasitol. 2009;95(4):891–894. doi: 10.1645/GE-1927.1. [DOI] [PubMed] [Google Scholar]
  • 37.Carlier Y, Sosa-Estani S, Luquetti AO, Buekens P. Congenital Chagas disease: an update. Mem Inst Oswaldo Cruz. 2015;110(3):363–368. doi: 10.1590/0074-02760140405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Alonso-Vega C, Hermann E, Truyens C, Rodriguez P, Torrico MC, Torrico F, et al. Estatus inmunológico de las madres infectadas por T. cruzi [Immunological status of mothers infected with Trypanosoma cruzi] Rev Soc Bras Med Trop. 2005;38(Suppl 2):101–104. [PubMed] [Google Scholar]
  • 39.Scapellato PG, Bottaro EG, Rodríguez-Brieschke MT. Mother-child transmission of Chagas disease: could coinfection with human immunodeficiency virus increase the risk? Rev Soc Bras Med Trop. 2009;42(2):107–109. doi: 10.1590/S0037-86822009000200002. [DOI] [PubMed] [Google Scholar]
  • 40.Bisio M, Altcheh J, Lattner J, Moscatelli G, Fink V, Burgos JM, et al. Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS. Emerg Infect Dis. 2013;19(9):1490–1492. doi: 10.3201/eid1909.130667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Castro CG de, Jr, Gregianin LJ, Brunetto AL. J Pediatr. 5. Vol. 77. Rio J: 2001. Transplante de medula óssea e transplante de sangue de cordão umbilical em pediatria; pp. 345–360. [DOI] [PubMed] [Google Scholar]
  • 42.Nisida IV, Amato V, Neto, Braz LM, Duarte MI, Umezawa ES. A survey of congenital Chagas' disease, carried out at three health institutions in São Paulo City, Brazil. Rev Inst Med Trop Sao Paulo. 1999;41(5):305–311. doi: 10.1590/S0036-46651999000500007. [DOI] [PubMed] [Google Scholar]
  • 43.Vekemans J, Truyens C, Torrico F, Solano M, Torrico MC, Rodriguez P, et al. Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines. Infect Immun. 2000;68(9):5430–5434. doi: 10.1128/IAI.68.9.5430-5434.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Agosti MR, Ercoli P, Dolcini G, Andreani G, Martínez Peralta L, González Ayala S. Two cases of mother-to-child transmission of HIV and Trypanosoma cruzi in Argentina. Braz J Infect Dis. 2012;16(4):398–399. doi: 10.1016/j.bjid.2012.06.008. [DOI] [PubMed] [Google Scholar]
  • 45.Fernández ML, Marson ME, Mastrantonio GE, Corti MA, Fleitas U, Lloveras SC, et al. Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients. Antimicrob Agents Chemother. 2021;65(3):e01922-20. doi: 10.1128/AAC.01922-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Portela-Lindoso AA, Shikanai-Yasuda MA. Doença de Chagas crônica: do xenodiagnóstico e hemocultura à reação em cadeia da polimerase [Chronic Chagas' disease: from xenodiagnosis and hemoculture to polymerase chain reaction]. Rev Saude Publica. 2003;37(1):107–115. doi: 10.1590/s0034-89102003000100016. [DOI] [PubMed] [Google Scholar]
  • 47.Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients- a review. Mem Inst Oswaldo Cruz. 2002;97(4):443–457. doi: 10.1590/S0074-02762002000400001. [DOI] [PubMed] [Google Scholar]
  • 48.Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, et al. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis. 2009;3(4):e419. doi: 10.1371/journal.pntd.0000419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Cura CI, Lattes R, Nagel C, Gimenez MJ, Blanes M, Calabuig E, et al. Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors. Am J Transplant. 2013;13(12):3253–3261. doi: 10.1111/ajt.12487. [DOI] [PubMed] [Google Scholar]
  • 50.Moreira OC, Ramírez JD, Velázquez E, Melo MF, Lima-Ferreira C, Guhl F, et al. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Acta Trop. 2013;125(1):23–31. doi: 10.1016/j.actatropica.2012.08.020. [DOI] [PubMed] [Google Scholar]
  • 51.Martinez-Perez A, Norman FF, Monge-Maillo B, Perez-Molina JA, Lopez-Velez R. An approach to the management of Trypanosoma cruzi infection (Chagas' disease) in immunocompromised patients. Expert Rev Anti Infect Ther. 2014;12(3):357–373. doi: 10.1586/14787210.2014.880652. [DOI] [PubMed] [Google Scholar]
  • 52.Burgos JM, Begher S, Silva HM, Bisio M, Duffy T, Levin MJ, et al. Molecular identification of Trypanosoma cruzi I tropism for central nervous system in Chagas reactivation due to AIDS. Am J Trop Med Hyg. 2008;78(2):294–297. [PubMed] [Google Scholar]
  • 53.Pacheco RS, Ferreira MS, Machado MI, Brito CM, Pires MQ, Da-Cruz AM, et al. Chagas' disease and HIV co-infection: genotypic characterization of the Trypanosoma cruzi strain. Mem Inst Oswaldo Cruz. 1998;93(2):165–169. doi: 10.1590/S0074-02761998000200005. [DOI] [PubMed] [Google Scholar]
  • 54.Burgos JM, Begher SB, Freitas JM, Bisio M, Duffy T, Altcheh J, et al. Molecular diagnosis and typing of Trypanosoma cruzi populations and lineages in cerebral Chagas disease in a patient with AIDS. Am J Trop Med Hyg. 2005;73(6):1016–1018. [PubMed] [Google Scholar]
  • 55.Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, Mejia Jaramillo AM, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011;5(1):e931. doi: 10.1371/journal.pntd.0000931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Duffy T, Cura CI, Ramirez JC, Abate T, Cayo NM, Parrado R, et al. Analytical performance of a multiplex Real-Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis. 2013;7(1):e2000. doi: 10.1371/journal.pntd.0002000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Andrade JP, Marin JA, Neto, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011;96(6):434–442. doi: 10.1590/S0066-782X2011000600002. [DOI] [PubMed] [Google Scholar]
  • 58.Marin-Neto JA, Rassi A, Jr, Oliveira GMM, Correia LCL, Ramos AN, Júnior, Luquetti AO, et al. SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023. Arq Bras Cardiol. 2023;120(6):e20230269. doi: 10.36660/abc.20230269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Vacas AS, Gomez-Santana LV, Torre AC, Galimberti RL. Reactivation of Chagas-Mazza disease during treatment with infliximab. An Bras Dermatol. 2017;92(6):899–900. doi: 10.1590/abd1806-4841.20177346. [DOI] [PubMed] [Google Scholar]
  • 60.Rassi A, Amato V, Neto, de Siqueira AF, Doles J, Leite MS, Silva OQ, et al. Influência de corticóide, na doença de Chagas crônica, administrado em virtude de afecções associdas. Rev Soc Bras Med Trop. 1997;30(2):93–99. doi: 10.1590/S0037-86821997000200002. [DOI] [PubMed] [Google Scholar]
  • 61.Lages-Silva E, Ramirez LE, Silva-Vergara ML, Chiari E. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis. 2002;34(1):118–123. doi: 10.1086/324355. [DOI] [PubMed] [Google Scholar]
  • 62.Pinazo MJ, Espinosa G, Cortes-Lletget C, Posada Ede J, Aldasoro E, Oliveira I, et al. Immunosuppression and Chagas disease: a management challenge. PLoS Negl Trop Dis. 2013;7(1):e1965. doi: 10.1371/journal.pntd.0001965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Molina I, Gómez i Prat J, Salvador F, Treviño B, Sulleiro E, Serre N, et al. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. N Engl J Med. 2014;370(20):1899–1908. doi: 10.1056/NEJMoa1313122. [DOI] [PubMed] [Google Scholar]
  • 64.Bacal F, Silva CP, Pires PV, Mangini S, Fiorelli AI, Stolf NG, et al. Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades. Clin Transplant. 2010;24(2):E29-34. doi: 10.1111/j.1399-0012.2009.01202.x. [DOI] [PubMed] [Google Scholar]
  • 65.Shikanai-Yasuda MA, Novaes C G, Freitas VLT, Carvalho NB. In: Epidemiologia e clínica da coinfecção Trypanosoma cruzi e vírus da imunodeficiência adquirida. 1st ed. Almeida EA, editor. Campinas: Unicamp; 2015. Experiência brasileira sobre a coinfecção T. cruzi/HIV; pp. 298–308. [Google Scholar]
  • 66.Schijman AG, Vigliano C, Burgos J, Favaloro R, Perrone S, Laguens R, et al. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. J Heart Lung Transplant. 2000;19(11):1114–1117. doi: 10.1016/S1053-2498(00)00168-6. [DOI] [PubMed] [Google Scholar]
  • 67.Ministério da Saúde (MS). Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis . Relatório de monitoramento clínico do HIV 2021. Brasília: MS; 2022. pp. 153–153.https://bvsms.saude.gov.br/bvs/publicacoes/relatorio_monitoramento_clinico_hiv_2021.pdf [Google Scholar]
  • 68.Silva VLC, Albuquerque LEJ. Prevalência de infecção pelo T. cruzi em doadores de sangue nos hemocentros coordenadores do Brasil em 2007. Epidemiol. Serv. Saúde. 2013;22(1):103–110. doi: 10.5123/S1679-49742013000100011. [DOI] [Google Scholar]
  • 69.Kransdorf EP, Zakowski PC, Kobashigawa JA. Chagas disease in solid organ and heart transplantation. Curr Opin Infect Dis. 2014;27(5):418–424. doi: 10.1097/QCO.0000000000000088. [DOI] [PubMed] [Google Scholar]
  • 70.Salvador F, Sánchez-Montalvá A, Valerio L, Serre N, Roure S, Treviño B, et al. Immunosuppression and Chagas disease; experience from a non-endemic country. Clin Microbiol Infect. 2015;21(9):854–860. doi: 10.1016/j.cmi.2015.05.033. [DOI] [PubMed] [Google Scholar]
  • 71.Stauffert D, Silveira MF, Mesenburg MA, Manta AB, Dutra AD, Bicca GL, et al. Prevalence of Trypanosoma cruzi/HIV coinfection in southern Brazil. Braz J Infect Dis. 2017;21(2):180–184. doi: 10.1016/j.bjid.2016.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.McCormack L, Quiñónez E, Goldaracena N, Anders M, Rodríguez V, Orozco Ganem F, et al. Liver transplantation using Chagas-infected donors in uninfected recipients: a single-center experience without prophylactic therapy. Am J Transplant. 2012;12(10):2832–2837. doi: 10.1111/j.1600-6143.2012.04160.x. [DOI] [PubMed] [Google Scholar]
  • 73.Sousa AA, Lobo MC, Barbosa RA, Bello V. Chagas seropositive donors in kidney transplantation. Transplant Proc. 2004;36(4):868–869. doi: 10.1016/j.transproceed.2004.03.113. [DOI] [PubMed] [Google Scholar]
  • 74.Lattes R, Lasala MB. Chagas disease in the immunosuppressed patient. Clin Microbiol Infect. 2014;20(4):300–309. doi: 10.1111/1469-0691.12585. [DOI] [PubMed] [Google Scholar]
  • 75.Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' Disease in the United States. Clin Microbiol Rev. 2011;24(4):655–681. doi: 10.1128/CMR.00005-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Hermann E, Truyens C, Alonso-Vega C, Rodriguez P, Berthe A, Torrico F, et al. Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon- gamma in response to parasite antigens. J Infect Dis. 2004;189(7):1274–1281. doi: 10.1086/382511. [DOI] [PubMed] [Google Scholar]
  • 77.Riarte A, Luna C, Sabatiello R, Sinagra A, Schiavelli R, De Rissio A, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis. 1999;29(3):561–567. doi: 10.1086/598634. [DOI] [PubMed] [Google Scholar]
  • 78.Chagas' Disease Argentine Collaborative Transplant Consortium Casadei D. Chagas' disease and solid organ transplantation. Transplant Proc. 2010;42(9):3354–3359. doi: 10.1016/j.transproceed.2010.09.019. [DOI] [PubMed] [Google Scholar]
  • 79.Diez M, Favaloro L, Bertolotti A, Burgos JM, Vigliano C, Lastra MP, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant. 2007;7(6):1633–1640. doi: 10.1111/j.1600-6143.2007.01820.x. [DOI] [PubMed] [Google Scholar]
  • 80.de Freitas VL, da Silva SC, Sartori AM, Bezerra RC, Westphalen EV, Molina TD, et al. Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level. PLoS Negl Trop Dis. 2011;5(8):e1277. doi: 10.1371/journal.pntd.0001277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Lescure FX, Le Loup G, Freilij H, Develoux M, Paris L, Brutus L, et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis. 2010;10(8):556–570. doi: 10.1016/S1473-3099(10)70098-0. [DOI] [PubMed] [Google Scholar]
  • 82.Britto CC. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz. 2009;104(Suppl 1):122–135. doi: 10.1590/S0074-02762009000900018. [DOI] [PubMed] [Google Scholar]
  • 83.Campos SV, Strabelli TM, Amato V, Neto, Silva CP, Bacal F, Bocchi EA, et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant. 2008;27(6):597–602. doi: 10.1016/j.healun.2008.02.017. [DOI] [PubMed] [Google Scholar]
  • 84.Dictar M, Sinagra A, Verón MT, Luna C, Dengra C, De Rissio A, et al. Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia. Bone Marrow Transplant. 1998;21(4):391–393. doi: 10.1038/sj.bmt.1701107. [DOI] [PubMed] [Google Scholar]
  • 85.Altclas J, Sinagra A, Dictar M, Luna C, Verón MT, De Rissio AM, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant. 2005;36(2):123–129. doi: 10.1038/sj.bmt.1705006. [DOI] [PubMed] [Google Scholar]
  • 86.Sánchez-Montalvá A, Salvador F, Ruiz-Camps I, Barba P, Valcárcel D, Sulleiro E, et al. Imported Disease Screening Prior to Chemotherapy and Bone Marrow Transplant ation for Oncohematological Malignancies. Am J Trop Med Hyg. 2016;95(6):1463–1468. doi: 10.4269/ajtmh.16-0458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Huprikar S, Bosserman E, Patel G, Moore A, Pinney S, Anyanwu A, et al. Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011. Am J Transplant. 2013;13(9):2418–2425. doi: 10.1111/ajt.12340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Pinazo MJ, Miranda B, Rodríguez-Villar C, Altclas J, Brunet Serra M, García-Otero EC, et al. Transplant Rev. 3. Vol. 25. Orlando: 2011. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas; pp. 91–101. [DOI] [PubMed] [Google Scholar]
  • 89.Coura JR, de Abreu LL, Willcox HP, Petana W. Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation. Rev Soc Bras Med Trop. 1997;30(2):139–144. doi: 10.1590/S0037-86821997000200009. [DOI] [PubMed] [Google Scholar]
  • 90.Dias JCP, Coura JR. Clínica e terapêutica da doença de Chagas: uma abordagem prática para o clínico geral. 1 st. Ed. Rio de Janeiro: Editora Fiocruz; 1997. 486 p [Google Scholar]
  • 91.Rassi A, Amato V, Neto, de Siqueira AF, Ferriolli F, Filho, Amato VS, Rassi A., Júnior Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases. Rev Soc Bras Med Trop. 1999;32(5):475–482. doi: 10.1590/S0037-86821999000500002. [DOI] [PubMed] [Google Scholar]
  • 92.Bern C. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis. 2012;25(4):450–457. doi: 10.1097/QCO.0b013e328354f179. [DOI] [PubMed] [Google Scholar]
  • 93.Lazo J, Meneses AC, Rocha A, Ferreira MS, Marquez JO, Chapadeiro E, et al. Chagasic meningoencephalitis in the immunodeficient. Arq Neuropsiquiatr. 1998;56(1):93–97. doi: 10.1590/S0004-282X1998000100015. [DOI] [PubMed] [Google Scholar]
  • 94.Benatti RD, Oliveira GH, Bacal F. Heart Transplantation for Chagas Cardiomyopathy. J Heart Lung Transplant. 2017;36(6):597–603. doi: 10.1016/j.healun.2017.02.006. [DOI] [PubMed] [Google Scholar]
  • 95.Reimer-McAtee MJ, Mejia C, Clark T, Terle J, Pajuelo MJ, Cabeza J, et al. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia. Am J Trop Med Hyg. 2021;105(3):643–650. doi: 10.4269/ajtmh.20-1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Gray EB, La Hoz RM, Green JS, Vikram HR, Benedict T, Rivera H, et al. Reactivation of Chagas disease among heart transplant recipients in the United States, 2012-2016. Transpl Infect Dis. 2018;20(6):e12996. doi: 10.1111/tid.12996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Salvador F, Len O, Molina I, Sulleiro E, Sauleda S, Bilbao I, et al. Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients. Liver Transpl. 2011;17(11):1304–1308. doi: 10.1002/lt.22346. [DOI] [PubMed] [Google Scholar]
  • 98.dos Santos-Neto LL, Polcheira MF, Castro C, Lima RA, Simaan CK, Corrêa-Lima FA. Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus. Rev Soc Bras Med Trop. 2003;36(5):613–615. [PubMed] [Google Scholar]
  • 99.Sánchez AG, Baenas DF, Bonisconti F, Salinas MJH, Alvarellos A, Saurit V, et al. Reactivation of Chagas Disease in Patients With Rheumatic Autoimmune Diseases Diagnosed by Molecular Quantification Techniques. J Clin Rheumatol. 2021;27(8S):S533–S536. doi: 10.1097/RHU.0000000000001108. [DOI] [PubMed] [Google Scholar]
  • 100.Balouz V, Agüero F, Buscaglia CA. Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps. Adv Parasitol. 2017;97:1–45. doi: 10.1016/bs.apar.2016.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90: uma meta ambiciosa de tratamento para contribuir para o fim da epidemia de Aids. 2015. https://unaids.org.br/wp-content/uploads/2015/11/2015_11_20_UNAIDS_TRATAMENTO_META_PT_v4_GB.pdf [Google Scholar]

Articles from Revista da Sociedade Brasileira de Medicina Tropical are provided here courtesy of Brazilian Society of Tropical Medicine

RESOURCES